Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
06/01/20233:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
06/01/20236:30AMBusiness WireIvonescimab Updated Data to be Featured at ASCO 2023NASDAQ:SMMTSummit Therapeutics Inc
05/25/20233:10PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
05/11/20233:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
05/11/20233:05PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SMMTSummit Therapeutics Inc
05/11/20236:30AMBusiness WireSummit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2023NASDAQ:SMMTSummit Therapeutics Inc
05/09/20233:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
05/09/20236:30AMBusiness WireSummit Therapeutics Announces First Patient Treated in Phase III HARMONi Clinical Trial Evaluating Ivonescimab (SMT112)NASDAQ:SMMTSummit Therapeutics Inc
05/03/20233:30PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
05/03/20237:30AMBusiness WireSummit Therapeutics Announces Initial Indications for Clinical Trials for Ivonescimab (SMT112)NASDAQ:SMMTSummit Therapeutics Inc
04/28/20235:20AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SMMTSummit Therapeutics Inc
04/21/202310:02AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:SMMTSummit Therapeutics Inc
03/17/20233:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
03/17/20233:26PMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SMMTSummit Therapeutics Inc
03/13/20233:53PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:SMMTSummit Therapeutics Inc
03/09/20233:56PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SMMTSummit Therapeutics Inc
03/09/20233:16PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
03/09/20236:30AMBusiness WireSummit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022NASDAQ:SMMTSummit Therapeutics Inc
03/08/20234:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
03/08/20233:59PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:SMMTSummit Therapeutics Inc
03/08/20233:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SMMTSummit Therapeutics Inc
03/03/20233:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
03/03/20237:00AMBusiness WireSummit Therapeutics Closes Fully-Subscribed $500 Million Rights OfferingNASDAQ:SMMTSummit Therapeutics Inc
02/23/20233:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
02/23/20237:00AMBusiness WireSummit Therapeutics’ Rights Offering Nearing Expiration DateNASDAQ:SMMTSummit Therapeutics Inc
02/07/20236:01AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:SMMTSummit Therapeutics Inc
01/30/20233:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
01/30/20237:00AMBusiness WireSummit Therapeutics Announces Timing for Rights Offering for Up to $500 MillionNASDAQ:SMMTSummit Therapeutics Inc
01/27/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SMMTSummit Therapeutics Inc
01/26/20231:50PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT